Assessing the prognostic value of preoperative carcinoembryonic antigen-specific T-cell responses in colorectal cancer
Current dogma suggests that tumor-reactive IFN-γ–producing (T<sub>H</sub>1-type) T-cells are beneficial to patient outcome; however, the clinical consequence of these responses with respect to long-term prognosis in colorectal cancer (CRC) is not understood. Here, we compared the utility...
Main Authors: | , , , , , , , |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Oxford University Press
2015
|
_version_ | 1797086245329829888 |
---|---|
author | Scurr, M Brown, C Bento, D Betts, G Rees, B Hills, R Gallimore, A Godkin, A |
author_facet | Scurr, M Brown, C Bento, D Betts, G Rees, B Hills, R Gallimore, A Godkin, A |
author_sort | Scurr, M |
collection | OXFORD |
description | Current dogma suggests that tumor-reactive IFN-γ–producing (T<sub>H</sub>1-type) T-cells are beneficial to patient outcome; however, the clinical consequence of these responses with respect to long-term prognosis in colorectal cancer (CRC) is not understood. Here, we compared the utility of preoperative, peripheral blood–derived IFN-γ<sup>+</sup> T-cell responses specific to carcinoembryonic antigen (CEA), 5T4, or control antigens (n = 64) with tumor staging and clinical details (n = 87) in predicting five-year outcome of CRC patients who underwent resection with curative intent. Although disease recurrence was more likely in patients with stage III tumors, the presence of preoperative, CEA-specific IFN-γ–producing T-cells identified patients at a statistically significantly greater risk of tumor recurrence following surgical resection, irrespective of tumor stage (odds ratio = 5.00, 95% confidence interval = 1.96 to 12.77, two-sided <em>P</em> <.001). Responses to other antigens, including 5T4, did not reflect outcome. Whilst these results initially appear surprising, they could improve prognostication and help redirect adjuvant treatments. |
first_indexed | 2024-03-07T02:19:22Z |
format | Journal article |
id | oxford-uuid:a3608cd9-a47d-4a2a-b713-7c051e391c48 |
institution | University of Oxford |
language | English |
last_indexed | 2024-03-07T02:19:22Z |
publishDate | 2015 |
publisher | Oxford University Press |
record_format | dspace |
spelling | oxford-uuid:a3608cd9-a47d-4a2a-b713-7c051e391c482022-03-27T02:26:32ZAssessing the prognostic value of preoperative carcinoembryonic antigen-specific T-cell responses in colorectal cancerJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:a3608cd9-a47d-4a2a-b713-7c051e391c48EnglishORA DepositOxford University Press2015Scurr, MBrown, CBento, DBetts, GRees, BHills, RGallimore, AGodkin, ACurrent dogma suggests that tumor-reactive IFN-γ–producing (T<sub>H</sub>1-type) T-cells are beneficial to patient outcome; however, the clinical consequence of these responses with respect to long-term prognosis in colorectal cancer (CRC) is not understood. Here, we compared the utility of preoperative, peripheral blood–derived IFN-γ<sup>+</sup> T-cell responses specific to carcinoembryonic antigen (CEA), 5T4, or control antigens (n = 64) with tumor staging and clinical details (n = 87) in predicting five-year outcome of CRC patients who underwent resection with curative intent. Although disease recurrence was more likely in patients with stage III tumors, the presence of preoperative, CEA-specific IFN-γ–producing T-cells identified patients at a statistically significantly greater risk of tumor recurrence following surgical resection, irrespective of tumor stage (odds ratio = 5.00, 95% confidence interval = 1.96 to 12.77, two-sided <em>P</em> <.001). Responses to other antigens, including 5T4, did not reflect outcome. Whilst these results initially appear surprising, they could improve prognostication and help redirect adjuvant treatments. |
spellingShingle | Scurr, M Brown, C Bento, D Betts, G Rees, B Hills, R Gallimore, A Godkin, A Assessing the prognostic value of preoperative carcinoembryonic antigen-specific T-cell responses in colorectal cancer |
title | Assessing the prognostic value of preoperative carcinoembryonic antigen-specific T-cell responses in colorectal cancer |
title_full | Assessing the prognostic value of preoperative carcinoembryonic antigen-specific T-cell responses in colorectal cancer |
title_fullStr | Assessing the prognostic value of preoperative carcinoembryonic antigen-specific T-cell responses in colorectal cancer |
title_full_unstemmed | Assessing the prognostic value of preoperative carcinoembryonic antigen-specific T-cell responses in colorectal cancer |
title_short | Assessing the prognostic value of preoperative carcinoembryonic antigen-specific T-cell responses in colorectal cancer |
title_sort | assessing the prognostic value of preoperative carcinoembryonic antigen specific t cell responses in colorectal cancer |
work_keys_str_mv | AT scurrm assessingtheprognosticvalueofpreoperativecarcinoembryonicantigenspecifictcellresponsesincolorectalcancer AT brownc assessingtheprognosticvalueofpreoperativecarcinoembryonicantigenspecifictcellresponsesincolorectalcancer AT bentod assessingtheprognosticvalueofpreoperativecarcinoembryonicantigenspecifictcellresponsesincolorectalcancer AT bettsg assessingtheprognosticvalueofpreoperativecarcinoembryonicantigenspecifictcellresponsesincolorectalcancer AT reesb assessingtheprognosticvalueofpreoperativecarcinoembryonicantigenspecifictcellresponsesincolorectalcancer AT hillsr assessingtheprognosticvalueofpreoperativecarcinoembryonicantigenspecifictcellresponsesincolorectalcancer AT gallimorea assessingtheprognosticvalueofpreoperativecarcinoembryonicantigenspecifictcellresponsesincolorectalcancer AT godkina assessingtheprognosticvalueofpreoperativecarcinoembryonicantigenspecifictcellresponsesincolorectalcancer |